Dynavax Technologies Corporation earnings per share and revenue
On 05 de nov. de 2025, DVAX reported earnings of 0.21 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 64.71% surprise. Revenue reached 94.88 milhão, compared to an expected 95.88 milhão, with a -1.05% difference. The market reacted with a +6.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of 0.03 USD, with revenue projected to reach 81.87 milhão USD, implying an diminuir of -85.71% EPS, and diminuir of -13.71% in Revenue from the last quarter.
FAQ
What were Dynavax Technologies Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dynavax Technologies Corporation reported EPS of $0.21, beating estimates by 64.71%, and revenue of $94.88M, -1.05% below expectations.
How did the market react to Dynavax Technologies Corporation's Q3 2025 earnings?
The stock price moved up 6.7%, changed from $10.30 before the earnings release to $10.99 the day after.
When is Dynavax Technologies Corporation expected to report next?
The next earning report is scheduled for 18 de fev. de 2026.
What are the forecasts for Dynavax Technologies Corporation's next earnings report?
Based on 5
analistas, Dynavax Technologies Corporation is expected to report EPS of $0.03 and revenue of $81.87M for Q4 2025.